UBS Group
BME icon

UBS Group’s BlackRock Health Sciences Trust BME Stock Holding History

UBS Group’s Portfolio BME Stock Details BME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.2M Buy
109,021
+4,735
+5% +$195K ﹤0.01% 4250
2025
Q4 		$4.29M Sell
104,286
-1,335
-1% -$52.7K ﹤0.01% 4185
2025
Q3 		$3.93M Sell
105,621
-10,602
-9% -$385K ﹤0.01% 4288
2025
Q2 		$4.24M Sell
116,223
-18,693
-14% -$678K ﹤0.01% 4044
2025
Q1 		$5.21M Sell
134,916
-4,674
-3% -$185K ﹤0.01% 3741
2024
Q4 		$5.29M Sell
139,590
-782
-0.6% -$31.2K ﹤0.01% 3790
2024
Q3 		$5.89M Sell
140,372
-1,562
-1% -$64.8K ﹤0.01% 2908
2024
Q2 		$5.8M Sell
141,934
-5,469
-4% -$218K ﹤0.01% 2717
2024
Q1 		$6.11M Buy
147,403
+39,828
+37% +$1.67M ﹤0.01% 2757
2023
Q4 		$4.35M Sell
107,575
-7,421
-6% -$283K ﹤0.01% 2924
2023
Q3 		$4.5M Buy
114,996
+29,793
+35% +$1.19M ﹤0.01% 2684
2023
Q2 		$3.46M Buy
85,203
+1,828
+2% +$75.2K ﹤0.01% 2964
2023
Q1 		$3.49M Buy
83,375
+18,248
+28% +$768K ﹤0.01% 2859
2022
Q4 		$2.84M Sell
65,127
-98,114
-60% -$4.17M ﹤0.01% 3028
2022
Q3 		$6.34M Buy
163,241
+3,377
+2% +$144K ﹤0.01% 2145
2022
Q2 		$6.78M Buy
159,864
+32,162
+25% +$1.4M ﹤0.01% 2119
2022
Q1 		$5.81M Buy
127,702
+18,288
+17% +$810K ﹤0.01% 2398
2021
Q4 		$5.31M Buy
109,414
+1,161
+1% +$55K ﹤0.01% 2753
2021
Q3 		$5.16M Buy
108,253
+2,267
+2% +$110K ﹤0.01% 2634
2021
Q2 		$5.14M Buy
105,986
+2,404
+2% +$115K ﹤0.01% 2651
2021
Q1 		$4.79M Buy
103,582
+135
+0.1% +$6.4K ﹤0.01% 2640
2020
Q4 		$4.92M Buy
103,447
+1,129
+1% +$51.2K ﹤0.01% 2464
2020
Q3 		$4.38M Buy
102,318
+10,415
+11% +$446K ﹤0.01% 2325
2020
Q2 		$3.75M Buy
91,903
+12,833
+16% +$518K ﹤0.01% 2278
2020
Q1 		$2.85M Buy
79,070
+28,419
+56% +$1.13M ﹤0.01% 2417
2019
Q4 		$2.15M Buy
50,651
+560
+1% +$22.2K ﹤0.01% 3480
2019
Q3 		$1.92M Buy
50,091
+4,493
+10% +$173K ﹤0.01% 3327
2019
Q2 		$1.77M Sell
45,598
-8,087
-15% -$307K ﹤0.01% 3251
2019
Q1 		$2.14M Buy
53,685
+2,004
+4% +$79.2K ﹤0.01% 2930
2018
Q4 		$1.88M Buy
51,681
+9,616
+23% +$378K ﹤0.01% 3092
2018
Q3 		$1.79M Buy
42,065
+1,192
+3% +$48.3K ﹤0.01% 3318
2018
Q2 		$1.58M Sell
40,873
-904
-2% -$32.8K ﹤0.01% 3374
2018
Q1 		$1.46M Sell
41,777
-5,462
-12% -$194K ﹤0.01% 3386
2017
Q4 		$1.73M Buy
47,239
+9,876
+26% +$357K ﹤0.01% 3322
2017
Q3 		$1.36M Buy
37,363
+696
+2% +$25.3K ﹤0.01% 3444
2017
Q2 		$1.34M Buy
36,667
+2,258
+7% +$79.1K ﹤0.01% 3354
2017
Q1 		$1.19M Buy
34,409
+5,624
+20% +$189K ﹤0.01% 3390
2016
Q4 		$914K Buy
28,785
+3,699
+15% +$124K ﹤0.01% 3616
2016
Q3 		$862K Buy
25,086
+3,930
+19% +$139K ﹤0.01% 3526
2016
Q2 		$754K Buy
21,156
+2,604
+14% +$95.2K ﹤0.01% 3601
2016
Q1 		$658K Sell
18,552
-190
-1% -$6.71K ﹤0.01% 3572
2015
Q4 		$738K Sell
18,742
-1,604
-8% -$65.4K ﹤0.01% 3646
2015
Q3 		$764K Buy
20,346
+2,462
+14% +$109K ﹤0.01% 3581
2015
Q2 		$765K Sell
17,884
-1,510
-8% -$64.9K ﹤0.01% 3772
2015
Q1 		$834K Buy
19,394
+819
+4% +$34.2K ﹤0.01% 3720
2014
Q4 		$793K Buy
+18,575
New +$764K ﹤0.01% 3756

Other funds holding BME

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
1CP
1607 Capital Partners Richmond, Virginia $1.39B AUM 8.35% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
NRW
Nova R Wealth Overland Park, Kansas $343M AUM 17.7% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
KIM
Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

UBS Group's BME Position: Q1 2026 in Review

UBS Group increased its BlackRock Health Sciences Trust (BME) stake by 4.5% in Q1 2026, buying an estimated $195K and bringing the position to 109,021 shares worth $4.2M. The position accounts for ﹤0.01% of the portfolio, ranked #4250.

UBS Group first reported a position in BME in Q4 2014 and has held it in 46 quarters since. The position peaked at $6.78M in Q2 2022. 76 funds tracked by Wall St. Rank hold BME as of Q1 2026.

  • UBS Group held 109,021 shares of BlackRock Health Sciences Trust worth $4.2M as of Q1 2026.
  • UBS Group bought 4,735 BlackRock Health Sciences Trust shares in Q1 2026, an estimated $195K.
  • BlackRock Health Sciences Trust made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #4250 holding.
  • UBS Group first reported a position in BlackRock Health Sciences Trust in Q4 2014 and has held it in 46 quarters since.
  • UBS Group's BlackRock Health Sciences Trust position peaked at $6.78M in Q2 2022.
  • 76 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.